News for hackers. Stuff that matters.

mchakravarti7

Hi! This is very interesting - I had a question but more so on the business side. I don't know much about finance, but what made you decide on a fixed fee pricing model than a take rate model like a hedge fund.
Hi all, I built Flock as a way to learn web development over the past few weeks. I've always struggled to figure out what I should gift my friends, and at the same time, there's also way too many things that I like as I browse through social media/the internet on any given day.

I attempted to solve these problems in one go by building Flock, where you can create wishlists from any items on the internet (i.e. you don't have to create a separate wishlist for Amazon, Best Buy items, etc.) for any (or no) occasion. Once you create a wishlist, you can then share it with family and friends, and they can contribute towards your wishlist GoFundMe style!

Here's my wishlist: https://myflock.app/@mohnish

This is the first time I've actually built and shipped something from scratch by myself. I'd love feedback on the design/technicality, and even take feature requests if you have any!

I built this using Node and React, and it is hosted on Firebase for now.

The amount of work/effort put in will have translated to something that's more easily quantifiable/measurable like growth (what kind differs from company to company), improvement in product or even the team. Agree with tzm -- you probably know best about what metrics you'd want to share in that response
There are VC firms that can help you work on an H1B, or even make you an employee in the short term. There's also programs in MA where an university can employ you on an H1B and let you work on your startup. I believe UMass Boston's VDC program is one. OPT is a completely valid option too (source: know a ton of people who have used this and have extensively spoken to attorneys about it)
You can use OPT, but would suggest not to so so because it will have implications on how long you can stay in the US after graduating. CPT is another option if your college allows you to use it. Post-graduation, OPT, H1-B, B1/B2 and O1 are all viable options of varying difficulty
There isn't really any benefit to incorporating in both places. If you incorporate in the US and in EU, you will have to pay taxes in both places. Unless you are raising a round and a VC insists on incorporating in the US, it will not make sense to register in both places.

There are lots of benefits to registering in DE compared to some other states in the US, but I'm unsure of any benefits compared to incorporating in the region you are based out of.

I'd suggest talking to an attorney and learning more about this before incorporating. Jared Stark (http://starkbusinesslaw.com/) helped us incorporate and is really helpful

International student founders – how did you solve the issue with visas?

Will need to incorporate soon, so I'm looking for advice on how to go on about eventual issues that will arise as an international student in the US. I'm currently on an F1 visa.As far as I understand, there's two options I can use immediately (until I find enough resources to move off the F1 visa): 1) CPT, 2) pre-OPT.Can I even use CPT to work on my startup? Would incorporating in my home...

( Read More... | no comments | on HN )
yes I emailed them, but I was wondering if there's anybody over here who could answer my question too

Post incorporation things to take care of while using Stripe Atlas

Currently in the process of evaluating services to use in order to incorporate a company, and I'm a bit confused about what post-incorporation documentation does Stripe Atlas actually provide help with. They say that they provide templates for all the documents, but what kind of documents are actually left to be submitted? the 83b form is one that comes to mind.I'd appreciate it if anybody who...

( Read More... | 2 comments | 3 points | on HN )
Re:Michael Seibel, CEO of YC, is doing an AMA on Friday March 17, 2017 @01:05PM (#13895705)
Hi Michael, thanks for the AMA. When you evaluate an early stage biotech startup, what would you say is the most important thing that you look for? - clinically validated products, or a solid long term business model?

With Trump picking Scott Gottlieb to be the next FDA commissioner, the FDA approval process is expected to get more lenient. Would you say that YC (or investors in general) would be open to take more risks with high tech startups that do not have a clinically validated product as of now?

One more question - Given that the FDA process takes a lot of time, quite a few biotech companies often get acquired or merged with bigger companies that can afford to do so, without ever having actually gotten their product out on the market. Would you say that you look at the company's potential return in that sense when you evaluate startups? I'm not entirely sure if this question makes sense, so let me know if you want me to clarify!